Paper41299728
Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics.
Vaziri Y and 3 others. Mol Brain, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics. Papers, record 41299728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41299728
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Dysbiosis | Major topic |
| Precision Medicine | Major topic |
| Humans | |
| Animals |
Source PubMed
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38849944 | Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial. | Alzheimers Res Ther | 2024 | https://conductscience.org/library/papers/38849944 | PubMed |
| 2 | 38791415 | Gut-Brain Axis: Focus on Sex Differences in Neuroinflammation. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791415 | PubMed |
| 3 | 32471946 | Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32471946 | PubMed |
| 4 | 39195495 | Systematic Insights into the Relationship between the Microbiota-Gut-Brain Axis and Stroke with the Focus on Tryptophan Metabolism. | Metabolites | 2024 | https://conductscience.org/library/papers/39195495 | PubMed |
| 5 | 36831324 | Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. | Cells | 2023 | https://conductscience.org/library/papers/36831324 | PubMed |
| 6 | 40137277 | The Advancements of Marine Natural Products in the Treatment of Alzheimer's Disease: A Study Based on Cell and Animal Experiments. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40137277 | PubMed |
| 7 | 38172602 | Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies. | Exp Mol Med | 2024 | https://conductscience.org/library/papers/38172602 | PubMed |
| 8 | 38916729 | Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis. | Aging Dis | 2024 | https://conductscience.org/library/papers/38916729 | PubMed |
| 9 | 38137351 | Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain Axis. | Biomedicines | 2023 | https://conductscience.org/library/papers/38137351 | PubMed |
| 10 | 39771027 | Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity. | Nutrients | 2024 | https://conductscience.org/library/papers/39771027 | PubMed |
| 11 | 39780269 | Fecal microbiota transplantation attenuates Alzheimer's disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation. | Behav Brain Funct | 2025 | https://conductscience.org/library/papers/39780269 | PubMed |
| 12 | 40791147 | Gut microbial metabolites and the brain-gut axis in Alzheimer's disease: A review. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40791147 | PubMed |
| 13 | 39460538 | The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/39460538 | PubMed |
| 14 | 35855330 | Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease. | Aging Dis | 2022 | https://conductscience.org/library/papers/35855330 | PubMed |
| 15 | 40243712 | Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243712 | PubMed |
| 16 | 40059063 | Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40059063 | PubMed |
| 17 | 36797287 | Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. | Sci Rep | 2023 | https://conductscience.org/library/papers/36797287 | PubMed |
| 18 | 39662839 | The complex relationship between gut microbiota and Alzheimer's disease: A systematic review. | Ageing Res Rev | 2025 | https://conductscience.org/library/papers/39662839 | PubMed |
| 19 | 39608999 | Monitoring drug Efficacy through Multi-Omics Research initiative in Alzheimer's Disease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer's disease. | BMJ Open | 2024 | https://conductscience.org/library/papers/39608999 | PubMed |
| 20 | 38717124 | Fecal microbiota transplantation: current challenges and future landscapes. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38717124 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974103 | The Gut-Brain Homeostatic Continuum in Alzheimer's disease: a systems framework for physiological resilience and disease progression. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42974103 | PubMed |
| 42877500 | The gut-brain axis in Alzheimer's and Parkinson's diseases: a comparative perspective. | Front Microbiomes | 2026 | https://conductscience.org/library/papers/42877500 | PubMed |
| 42794551 | The Tryptophan-Kynurenine Pathway as a Key Mediator of the Gut-Brain Axis in Depression and Alzheimer's Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794551 | PubMed |
| 42630799 | The potential connection between inflammatory bowel disease and Alzheimer's disease: mechanistic insights and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42630799 | PubMed |
| 42321809 | Bacteria-derived glutarate mitigates Alzheimer's disease model pathology through autophagy-lysosomal pathway. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42321809 | PubMed |
| 42319691 | A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42319691 | PubMed |
| 42223629 | The complex of gut microbial metabolites and sex hormones in Alzheimer's disease. | Semin Immunopathol | 2026 | https://conductscience.org/library/papers/42223629 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41299728
GET https://conductscience.org/api/papers/v1/41299728/references?page=2